BioPharmX Corp fka BPMX

[Sumfest]

Hey guys,

Just did some research on BPMX’ behavior of releasing clinical trial data after study completion dates. Usually, the company releases study data within 3-5 weeks after the completion date.

________________________________________________________________________
________________________________________________________________________

Evidence 1:

Study: BPX-01 Randomized, Double-blind, Vehicle Controlled Study to Assess the Safety and Efficacy of BPX-01 Minocycline Topical Gel in the Treatment of Moderate to Severe Inflammatory Acne Vulgaris

Study Start Date: August 2016
Actual Study Completion Date: March 24, 2017
Last Update Posted: April 14, 2017

Official announcement by BPMX on May 3, 2017:

“BioPharmX Reports Positive Topline Results of BPX-01 Topical Minocycline for Acne”

About 4 weeks after the completion date, the company released the study results.

________________________________________________________________________
________________________________________________________________________


Evidence 2:

Study: Administration of Oral Extended Release Minocycline for Assessment of Skin and Plasma Concentrations of Minocycline

Study Start Date: April 2016
Actual Study Completion Date: June, 2016

Official announcement by BPMX on June 29, 2016:

“BioPharmX Announces Positive Topline Phase 2a Clinical Trial Results for BPX-01 in Patients with Acne-Causing Bacteria”

About 4 weeks after the study completion date, the company released the study results.

________________________________________________________________________
________________________________________________________________________




Current studies, where results should be released within a few days/weeks.


BPX-01 Open Label Study to Document the Treatment Effect of 1 and 2% BPX-01 Minocycline Topical Gel in Moderate to Severe Inflammatory Non-nodular Acne Vulgaris.

Click here to see the study layout


The study has been marked as completed on June 1, 2018. Given BPMX’ history of releasing study data within 3-5 weeks after the completion date, we should see an official release in the next days.


There is also an “Open Label Study to Document the Treatment Effect of 1 and 2% BPX-01 Minocycline Topical Gel in Moderate to Severe Inflammatory Non-nodular Acne Vulgaris (Protocol Number BPX-01-C04)“ with an estimated completion date on June 30, 2018. I expect study results within July Q2.


Btw, this is KingBiotech. I'm just using another account!

You can also ready my Analysis on BPMX' Main Catalysts

Disclaimer: This text solely represents my own opinion and should not be seen as investment advice.